The application of chitosan/collagen/hyaluronic acid sponge cross-linked by dialdehyde starch addition as a matrix for calcium phosphate in situ precipitation

2018 ◽  
Vol 107 ◽  
pp. 470-477 ◽  
Author(s):  
B. Kaczmarek ◽  
A. Sionkowska ◽  
A.M. Osyczka
2016 ◽  
Vol 17 (3) ◽  
pp. 841-851 ◽  
Author(s):  
Seol-Ha Jeong ◽  
Young-Hag Koh ◽  
Suk-Wha Kim ◽  
Ji-Ung Park ◽  
Hyoun-Ee Kim ◽  
...  

2014 ◽  
Vol 11 (2) ◽  
pp. 122-129 ◽  
Author(s):  
Wafaa Ahmed Omar Segari ◽  
Dalia Abd El Khalek Radwan ◽  
Mohamed Ayad Abd El Hamid

2006 ◽  
Vol 309-311 ◽  
pp. 857-860 ◽  
Author(s):  
Q. Yao ◽  
Dong Xiao Li ◽  
K.W. Liu ◽  
Bo Zhang ◽  
H. Li ◽  
...  

This study was to develop an injectable biocompatible and porous calcium phosphate collagen composite cement scaffold by in situ setting. TTCP was prepared as main material of the CPC powder, and the collagen solution was added into the phosphoric acid directly to form the liquid phase. The injectable time (tI), setting time (tS) and setting temperature (TS), along with the PH value were recorded during the setting process. The compressive strength, morphology and porosity were tested. With the increase of collagen, this novel CPC get a tI of 5mins to 8mins, tS of 20mins to 30mins, compressive strength from 1.5MPa to 4MPa, and the porosity from 40% to 60%. This study gave a possibility to form a porous scaffold of collagen/CPC composite with the nature of injectability and setting in situ.


2017 ◽  
Vol 74 (10) ◽  
pp. 4069-4085 ◽  
Author(s):  
Takeshi Sato ◽  
Takao Aoyagi ◽  
Mitsuhiro Ebara ◽  
Rachel Auzély-Velty

Author(s):  
Coathup Melanie ◽  
Kent Niall ◽  
Hill Robert ◽  
Ferro De Godoy Roberta ◽  
Quak Wenyu ◽  
...  

Author(s):  
Mirella Romanelli Vicente Bertolo ◽  
Virginia Conceição Amaro Martins ◽  
Ana Maria De Guzzi Plepis

In this study, we evaluated how different procedures of calcium phosphate synthesis and its incorporation in collagen:chitosan scaffolds could affect their structural and thermal properties, aiming the obtention of homogeneous scaffolds which can act as drug delivery vehicles in bone tissue engineering. Therefore, three different scaffold preparation procedures were developed, changing the order of addition of the components: in CC-CNPM1 and CC-CNPM2, calcium phosphate synthesis was performed in situ in the chitosan gel (1%, w/w) followed by mixture with collagen (1%, w/w), with changes in the reagents used for calcium phosphate formation; in CC-CNPM3 procedure, calcium phosphate was synthesized ex situ and then incorporated into the collagen gel, in which chitosan in powder was mixed. In all procedures, 5% (in dry mass) of ciprofloxacin was incorporated. FTIR analysis confirmed the presence of calcium phosphate in all scaffolds. DSC curves showed that collagen denaturation temperature (Td) increased with calcium incorporation. SEM photomicrographs of scaffolds cross-section revealed porous scaffolds with calcium phosphate grains internally distributed in the polymeric matrix. XRD diffractograms indicated that the calcium phosphates obtained are hydroxyapatite. The pore size distribution was more homogeneous for CC-CNPM3, which also stood out for its smaller porosity and lower absorption in PBS. These results indicate that the in situ or ex situ phosphate incorporation in the scaffolds had a great influence on its structural properties, which also had consequences for ciprofloxacin release. CC-CNPM3 released a smaller amount of antibiotic (30%), but its release profile was better described by all the tested models.


Sign in / Sign up

Export Citation Format

Share Document